发明名称 |
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use |
摘要 |
In T lymphocytes, p38 mitogen activated protein kinase (MAPK) can be activated through an alternative pathway that involves phosphorylation at tyrosine 323. Disclosed herein is the identification of a minimal region of the growth arrest and DNA damage-inducible alpha (Gadd45α) protein that is required for binding to and inhibition of tyrosine 323-phosphorylated p38 in T cells. The disclosed Gadd45α polypeptides inhibit proliferation of T cells in response to T cell receptor stimulation, inhibit differentiation of T cells into Th1 or Th17 cells, inhibit the production of proinflammatory cytokines, and reduce tumor formation and growth of inflammatory cancers, such as pancreatic cancer. |
申请公布号 |
US9359418(B2) |
申请公布日期 |
2016.06.07 |
申请号 |
US201314443278 |
申请日期 |
2013.11.19 |
申请人 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
发明人 |
Ashwell Jonathan D.;Alam Muhammad S. |
分类号 |
C07K14/00;C07K14/475;A61K38/00 |
主分类号 |
C07K14/00 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. An isolated growth arrest and DNA-damage-inducible alpha (Gadd45α) polypeptide no more than 25 amino acids in length, wherein the amino acid sequence of the polypeptide comprises LQIHFTLIXAFCCEN (SEQ ID NO: 1), wherein X is Q or R. |
地址 |
Washington DC US |